AB58. Phase II study of safety and clinical outcome for Nimotuzumab and concurrent capecitabine and radiotherapy for patients with locally advanced inoperable or relapsed/ residual gastric cancer
2013
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI